InChI=1S/C16H26O7/c17- 10(3- 1- 2- 4- 15(20) 21) 5- 6- 11- 12(7- 8- 16(22) 23) 14(19) 9- 13(11) 18/h11- 14,18- 19H,1- 9H2,(H,20,21) (H,22,23) /t11- ,12- ,13- ,14+/m1/s1 |
IGRHJCFWWOQYQE-SYQHCUMBSA-N |
O[C@H]1C[C@@H](O)[C@H](CCC(=O)CCCCC(O)=O)[C@H]1CCC(O)=O |
|
Bronsted acid
A molecular entity capable of donating a hydron to an acceptor (Bronsted base).
(via oxoacid )
|
|
metabolite
Any intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites.
|
|
View more via ChEBI Ontology
Outgoing
|
2,3,4,5-tetranor-prostaglandin FM
(CHEBI:73989)
has role
metabolite
(CHEBI:25212)
2,3,4,5-tetranor-prostaglandin FM
(CHEBI:73989)
is a
ketone
(CHEBI:17087)
2,3,4,5-tetranor-prostaglandin FM
(CHEBI:73989)
is a
oxo dicarboxylic acid
(CHEBI:36145)
2,3,4,5-tetranor-prostaglandin FM
(CHEBI:73989)
is a
prostanoid
(CHEBI:26347)
2,3,4,5-tetranor-prostaglandin FM
(CHEBI:73989)
is a
secondary alcohol
(CHEBI:35681)
|
|
8- [(1R,2R,3S,5R)- 2- (2- carboxyethyl)- 3,5- dihydroxycyclopentyl]- 6- oxooctanoic acid
|
9α,11α,dihydroxy-2,3,4,5-tetranor-15-oxo-prostan-1,20-dioic acid
|
(9S,11R)-dihydroxy-15-oxo-2,3,4,5-tetranor-prostan-1,20-dioic acid
|
ChEBI
|
2,3,4,5-tetranor-PGFM
|
ChEBI
|
2,3,4,5-tetranor-prostaglandin F metabolite
|
ChEBI
|
9S,11R-dihydroxy-15-oxo-2,3,4,5-tetranor-prostan-1,20-dioic acid
|
LIPID MAPS
|
tetranor-PGFM
|
LIPID MAPS
|
tetranor-prostaglandin F metabolite
|
ChEBI
|
tetranor-prostaglandin FM
|
LIPID MAPS
|
2999249
|
Reaxys Registry Number
|
Reaxys
|
|